Christina Ackermann

Christina Ackermann

Director/Board Member chez OCULIS HOLDING AG

Fortune : 6 M $ au 31/03/2024

59 ans
Health Technology
Consumer Services

Profil

Christina Maria Ackermann is currently serving as the Secretary & Director at Synergetics USA, Inc. She is also an Independent Non-Executive Director at Verona Pharma Plc, a Co-Managing Director at Dr. Robert Winzer Pharma GmbH, an Independent Director at Oculis Holding AG, and the Head-Commercial Operations at Bausch Health Cos., Inc. In her former roles, Ms. Ackermann has worked as an Independent Director at Graybug Vision, Inc., an Associate General Counsel at DuPont Pharmaceuticals Co., a Senior Vice President & General Counsel at Alcon Laboratories, Inc., the General Counsel & Global Head-Legal at Sandoz International GmbH, an Associate General Counsel at Bristol-Myers Squibb Pharma Co., and the Head-Legal Technical Operations & Ophthalmics at Novartis Pharma AG.
She has also served as the President, Executive VP & General Counsel at Bausch + Lomb Corp.Ms. Ackermann completed her undergraduate studies at York University and pursued graduate degrees at Queen's University and King's College London.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/03/2023 358 285 ( 0,10% ) 4 M $ 31/03/2024
01/03/2023 146 677 ( 0,04% ) 3 M $ 31/03/2024
31/12/2023 11 718 ( 0,03% ) 141 202 $ 31/03/2024
23/03/2023 1 420 ( 0,01% ) 5 907 $ 31/03/2024

Postes actifs de Christina Ackermann

SociétésPosteDébut
BAUSCH HEALTH COMPANIES INC. Corporate Officer/Principal 01/07/2020
SYNERGETICS USA INC Director/Board Member -
OCULIS HOLDING AG Director/Board Member 03/03/2023
VERONA PHARMA PLC Director/Board Member 01/09/2023
Chief Executive Officer 27/02/2017
Tous les postes actifs de Christina Ackermann

Anciens postes connus de Christina Ackermann

SociétésPosteFin
BAUSCH + LOMB CORPORATION President 24/04/2023
General Counsel 01/08/2016
General Counsel 01/01/2012
Bristol-Myers Squibb Pharma Co. Corporate Officer/Principal 01/04/2002
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Christina Ackermann

Formation de Christina Ackermann

York University Undergraduate Degree
Queen's University Graduate Degree
King's College London Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christina Ackermann

Relations

100 +

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
VERONA PHARMA PLC

Health Technology

BAUSCH HEALTH COMPANIES INC.

Health Technology

BAUSCH + LOMB CORPORATION

Health Technology

OCULIS HOLDING AG

Health Technology

Entreprise privées8

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Bristol-Myers Squibb Pharma Co.

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Christina Ackermann